News
Learn how AI in drug discovery is revolutionizing therapeutic development and addressing challenges in cell and gene therapy.
Monash University scientists have identified a potential new drug target to alleviate neuroinflammation, which is reported in ...
Explore the evolving landscape of clinical trials in drug discovery and learn about recent breakthroughs transforming the ...
Pre-Clinical Drug Discovery Services Market to grow through 2035, driven by rising chronic diseases and increased outsourcing of early-stage R&D.
The global drug discovery services market is projected to grow at a CAGR of 15% from 2025 to 2030. This growth is driven by ...
Neurological disorders, including Alzheimer’s, Parkinson’s, ALS, and multiple sclerosis, pose significant challenges due to their complex pathophysiology ...
SAN DIEGO--(BUSINESS WIRE)--Sapient, a leader in multi-omics data generation for biomarker discovery and clinical ... of samples — enables rapid drug target identification, biomarker discovery ...
A team of scientists has uncovered the mechanism of cellular uptake for large and polar drugs and devised a novel strategy to ...
Intellomx Launches Swarm-Based AI Platform to Accelerate and De-Risk Novel Target and Drug Discovery
Intellomx announces its' new Pilot platform, delivering rapid identification of novel drugs arising from its therapeutic ...
Chem, a global leader in DNA-encoded library (DEL) technology and data-driven drug discovery, has announced an expanded ...
The company’s DynamiQ™ Insights Engine — a longitudinal database of integrated multi-omics and real-world data collected from tens of thousands of samples — enables rapid drug target identification, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results